by Wajeeha Malik | Apr 17, 2024 | Uncategorised
ISARIC and WHO will be collaborating to organise a webinar to discuss the dengue core outcome set project (den-core) in the context of dengue clinical trials. When: 22 April from 13:00 to 14:35 (UTC+1) Registration: Visit this link to register for the event by 20...
by Wajeeha Malik | Jan 15, 2024 | News
More than 25 years since the Nipah virus was discovered in Malaysia, there are still no approved vaccines or treatments available for this deadly disease. To unlock scientific progress on Nipah virus, researchers at Bangladesh’s International Centre for Diarrheal...
by Wajeeha Malik | Dec 18, 2023 | Frameworks, News, Research
18 December 2023: The International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) is working with partners to create a framework to support endpoint selection for clinical trials for outbreak-prone infectious diseases. The project members, which...
by Eamonn | Jul 8, 2021 | News
Ribavirin is the only available Lassa fever–specific treatment and has been used routinely for over 25 years. However, Ribavirin is not licensed for Lassa fever, its mechanism of action is unclear, it’s expensive and hard to source, and it has well-known...
by Eamonn | Mar 10, 2021 | News
In the largest study of its kind to date, the UK’s International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC), supported by the UK Coronavirus Immunology Consortium (UK-CIC), has identified new biomarkers of inflammation that both indicate the...
